Literature DB >> 21932397

Surveillance for hepatocellular carcinoma: a standard of care, not a clinical option.

Angelo Sangiovanni, Massimo Colombo.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21932397     DOI: 10.1002/hep.24684

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  5 in total

1.  Effects of statins on the risk of hepatocellular carcinoma.

Authors:  Pejman G Mansourian; Masato Yoneda; M Krishna Rao; Fernando J Martinez; Emmanuel Thomas; Eugene R Schiff
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-07

Review 2.  Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV.

Authors:  Amedeo Lonardo; Stefano Ballestri; Giovanni Guaraldi; Fabio Nascimbeni; Dante Romagnoli; Stefano Zona; Giovanni Targher
Journal:  World J Gastroenterol       Date:  2016-11-28       Impact factor: 5.742

3.  Detailed analysis of temporal features on contrast enhanced ultrasound may help differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma in cirrhosis.

Authors:  Rui Li; Meng-Xia Yuan; Kuan-sheng Ma; Xiao-Wu Li; Chun-Lin Tang; Xiao-Hang Zhang; De-Yu Guo; Xiao-Chu Yan
Journal:  PLoS One       Date:  2014-05-29       Impact factor: 3.240

4.  Dynamic enhancement patterns of intrahepatic cholangiocarcinoma in cirrhosis on contrast-enhanced computed tomography: risk of misdiagnosis as hepatocellular carcinoma.

Authors:  Rui Li; Ping Cai; Kuan-Sheng Ma; Shi-Yi Ding; De-Yu Guo; Xiao-Chu Yan
Journal:  Sci Rep       Date:  2016-05-26       Impact factor: 4.379

5.  Socioeconomic disparities in access to a hepatocellular carcinoma screening program in Brazil.

Authors:  Izabelle Venturini Signorelli; Patrícia Lofêgo Gonçalves; Luciana Lofêgo Gonçalves; Luiz Sérgio Emery Ferreira; Ana Tereza Parpaiola Mendonça; Gustavo Leite Franklin; Maria da Penha Zago Gomes
Journal:  Clinics (Sao Paulo)       Date:  2016-07       Impact factor: 2.365

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.